Longevityy.ai - About the company
Longevityy.ai is a funded company, founded in 2026. It operates as a Developer of genetic health analysis reports using clinical research databases. The company has 543 active competitors, including 82 funded and 25 that have exited. Its top competitors include companies like MyHeritage, 23andMe and Helix.
Company Details
Developer of genetic health analysis reports using clinical research databases. This platform transforms raw genetic data into structured health reports by utilizing information from clinical databases. It provides insights into drug and gene interactions, screens for clinical variants, and generates personalized protocols for nutrition and supplements. Additionally, the service includes tools for tracking blood biomarkers and monitoring lifestyle metrics to support wellness management.
Key Metrics
Sign up to download Longevityy.ai's company profile
Longevityy.ai's funding and investors
Longevityy.ai is a funded company. Longevityy.ai has 1 institutional investor.
View details of Longevityy.ai's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Longevityy.ai's Competitors and alternates
Top competitors of Longevityy.ai include MyHeritage, 23andMe and Helix. Here is the list of Top 10 competitors of Longevityy.ai, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | MyHeritage 2003, Yehud (Israel), Acquired | Provider of tools for creating family trees and exploring ancestry | $49M | 77/100 | |
2nd | 23andMe 2006, Sunnyvale (United States), Acquired | Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | $944M | 77/100 | |
3rd | Helix 2015, San Francisco (United States), Series E | Provider of a genomic database for clinical research | $435M | 71/100 | |
4th | Color 2013, Burlingame (United States), Series E | Provider of end-to-end Virtual clinic offering cancer-based solutions | $491M | 66/100 | |
5th | Nucleus Genomics 2021, Manhattan (United States), Series A | Provider of genetic testing kits for rare variant analysis | $32M | 62/100 | |
6th | MyOme 2017, San Carlos (United States), Series B | Provider of a platform for gene analysis to determine genetic diseases and drug response | $36M | 61/100 | |
7th | GenePlanet 2008, Ljubljana (Slovenia), Series B | Genetics-based health and fitness recommendations | $34M | 60/100 | |
8th | Dante Labs 2016, New York City (United States), Seed | Provider of whole-genome sequencing analysis for health and wellness | - | 60/100 | |
9th | Genomind 2009, King Of Prussia (United States), Series C | Developer of genetic tests for personalised medicines to enhance mental health treatment | $64.4M | 56/100 | |
10th | Veritas Genetics 2014, Danvers (United States), Acquired | Provider of genetic testing products | $53.4M | 55/100 | |
727th | Longevityy.ai 2026, Funding Raised | Developer of genetic health analysis reports using clinical research databases | - | 15/100 |
Looking for more details on Longevityy.ai's competitors? Click here to see the top ones
Longevityy.ai's Investments and acquisitions
Longevityy.ai has made no investments or acquisitions yet.
Reports related to Longevityy.ai
Here is the latest report on Longevityy.ai's sector:
Are you a Founder ?
FAQs about Longevityy.ai
Explore our recently published companies
- The Billiard Pros - Atlanta based, 2004 founded, Unfunded company
- Poultryfeeds - Unfunded company
- Meritzone Education - India based, 2014 founded, Unfunded company
- THE PACKMAN - Noida based, 2016 founded, Unfunded company
- Sandy Saga - Unfunded company
- Fields - Unfunded company
